Bicycle Therapeutics PLC (BCYC)
NASDAQ: BCYC · IEX Real-Time Price · USD
17.49
+0.71 (4.23%)
At close: Jul 1, 2022 4:00 PM
17.25
-0.24 (-1.37%)
After-hours:
Jul 1, 2022 5:34 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Revenue
|
11.7 | 10.39 | 13.8 | 7.14 | 2.06 |
| Revenue Growth (YoY)
|
12.58% | -24.72% | 93.40% | 246.41% | - |
| Gross Profit
|
11.7 | 10.39 | 13.8 | 7.14 | 2.06 |
| Selling, General & Admin
|
32.44 | 29.2 | 14.56 | 8.12 | 6.41 |
| Research & Development
|
44.88 | 33.15 | 25.54 | 20.76 | 11.87 |
| Operating Expenses
|
77.32 | 62.35 | 40.1 | 28.88 | 18.27 |
| Operating Income
|
-65.62 | -51.96 | -26.3 | -21.75 | -16.21 |
| Interest Expense / Income
|
2.98 | 0.46 | 0 | 0 | 0 |
| Other Expense / Income
|
-0.12 | -0.68 | 4.56 | 0.5 | 0.07 |
| Pretax Income
|
-68.48 | -51.73 | -30.86 | -22.24 | -16.28 |
| Income Tax
|
-1.66 | -0.72 | -0.25 | -0.4 | -0.02 |
| Net Income
|
-66.82 | -51.01 | -30.61 | -21.85 | -16.26 |
| Net Income Common
|
-66.82 | -51.01 | -30.61 | -21.85 | -16.26 |
| Shares Outstanding (Basic)
|
25 | 19 | 11 | 0 | 0 |
| Shares Outstanding (Diluted)
|
25 | 19 | 11 | 0 | 0 |
| Shares Change
|
30.90% | 73.34% | 2416.82% | 31.74% | - |
| EPS (Basic)
|
-2.67 | -2.66 | -2.77 | -49.78 | -48.81 |
| EPS (Diluted)
|
-2.67 | -2.66 | -2.77 | -49.78 | -48.81 |
| Free Cash Flow Per Share
|
-0.67 | -0.99 | -2.73 | -62.12 | -7.59 |
| Gross Margin
|
100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Margin
|
-560.98% | -500.10% | -190.56% | -304.74% | -787.04% |
| Profit Margin
|
-571.25% | -490.95% | -221.78% | -306.14% | -789.27% |
| Free Cash Flow Margin
|
-143.83% | -182.76% | -218.59% | -382.06% | -122.72% |
| Effective Tax Rate
|
2.43% | 1.40% | 0.82% | 1.78% | 0.14% |
| EBITDA
|
-64.09 | -50 | -29.9 | -21.53 | -15.95 |
| EBITDA Margin
|
-547.91% | -481.23% | -216.67% | -301.71% | -774.27% |
| Depreciation & Amortization
|
1.41 | 1.28 | 0.96 | 0.71 | 0.33 |
| EBIT
|
-65.5 | -51.28 | -30.86 | -22.24 | -16.28 |
| EBIT Margin
|
-559.96% | -493.52% | -223.62% | -311.69% | -790.39% |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).